Quote

NTLX NTLX

—

Price & news catalysts

No price data available for NTLX.

What moved NTLX

No scored catalysts in the window yet.

Key statistics

Market cap

—

P/E

—

EPS

—

Beta

—

52W range

—

Day range

—

Open

—

Prev close

—

Volume

—

Avg volume

—

Dividend

—

IPO

—

Latest NTLX news

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
https://www.globenewswire.com/news-release/2026/07/29/3335231/0/en/SciSparc-Subsidiary-NeuroThera-Labs-Advances-its-Quantum-Platform-for-Clinical-Data-Analytics-on-a-Platform-of-an-S-P-500-company.html · 7/29/2026+0.80
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
https://www.globenewswire.com/news-release/2026/07/15/3327736/0/en/SciSparc-NeuroThera-Labs-Announces-Initiation-of-Phase-IIb-Clinical-Trial-at-Hannover-Medical-School-in-Germany-for-Innovative-Treatment-of-Tourette-Syndrome.html · 7/15/2026+0.60

Profile

Sector: —
Industry: —
CEO: —
Employees: —
Country: —

Free · No account

Track these names every morning.

Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.

We’ll watch

$NTLX

Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.

Free forever · one email a day, max · unsubscribe in one click.How it works